Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

News
ASAM partners on training of NPs, PAs in buprenorphine prescribing
01/17/2017
The American Society of Addiction Medicine (ASAM) has partnered with associations representing nurse practitioners and physician assistants to offer training courses for these professionals in buprenorphine prescribing.
The American Society of Addiction Medicine (ASAM) has partnered with associations representing nurse practitioners and physician assistants to offer training courses for these professionals in buprenorphine prescribing.
The American Society of...
01/17/2017
Addiction Professional
Five facts about new versions of buprenorphine
01/13/2017
Injectable and implant versions of buprenorphine are seen as potentially significant breakthroughs in improving medication adherence and reducing diversion.
Injectable and implant versions of buprenorphine are seen as potentially significant breakthroughs in improving medication adherence and reducing diversion.
Injectable and implant versions...
01/13/2017
Addiction Professional
News
FDA will remove warning language on drugs for smoking cessation
12/19/2016
Results of a clinical trial have convinced the Food and Drug Administration (FDA) that the risk of neuropsychiatric adverse events from the brand-name drugs Chantix and Zyban is lower than originally believed.
Results of a clinical trial have convinced the Food and Drug Administration (FDA) that the risk of neuropsychiatric adverse events from the brand-name drugs Chantix and Zyban is lower than originally believed.
Results of a clinical trial have...
12/19/2016
Addiction Professional
Settlement over prescribing practices puts spotlight on buprenorphine clinics
12/02/2016
A well-regarded chain of buprenorphine treatment operations has agreed to pay a civil settlement in a case that in part speaks to concerns about the mix of services in medication-assisted treatment facilities.
A well-regarded chain of buprenorphine treatment operations has agreed to pay a civil settlement in a case that in part speaks to concerns about the mix of services in medication-assisted treatment facilities.
A well-regarded chain of...
12/02/2016
Addiction Professional
News
App from SAMHSA guides medication treatment for opioid dependence
12/01/2016
The new MATx app is designed to share treatment strategies and other resources for the use of medications to treat opioid use disorders.
The new MATx app is designed to share treatment strategies and other resources for the use of medications to treat opioid use disorders.
The new MATx app is designed to...
12/01/2016
Addiction Professional
Transformed thinking gives rise to center of excellence in addiction medicine
11/23/2016
In establishing unified addiction services that earned a first-ever recognition this month, the Center for Addiction Science in Tennessee showed how patients can flourish when they receive care in a humane manner.
In establishing unified addiction services that earned a first-ever recognition this month, the Center for Addiction Science in Tennessee showed how patients can flourish when they receive care in a humane manner.
In establishing unified...
11/23/2016
Addiction Professional
Midlevel practitioners will soon prescribe buprenorphine
11/22/2016
A new 2017 federal policy will allow physician assistants and nurse practitioners to prescribe buprenorphine. Previously, only physicians were authorized to prescribe the medication.
A new 2017 federal policy will allow physician assistants and nurse practitioners to prescribe buprenorphine. Previously, only physicians were authorized to prescribe the medication.
A new 2017 federal policy will...
11/22/2016
Addiction Professional
Opioid treatment program weaves in hepatitis C care, despite payment obstacles
11/07/2016
The potential of newer drugs to treat the hepatitis C virus has helped drive Rhode Island organization CODAC Inc.'s move to establish an on-site HCV clinic.
The potential of newer drugs to treat the hepatitis C virus has helped drive Rhode Island organization CODAC Inc.'s move to establish an on-site HCV clinic.
The potential of newer drugs to...
11/07/2016
Addiction Professional
Methadone remains vital in buprenorphine era
10/20/2016
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.
Opioid treatment leaders see the...
10/20/2016
Addiction Professional
News
Alkermes establishes grant program for nonprofits
09/16/2016
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.
The maker of injectable...
09/16/2016
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement